Ablation Frontiers Acquisition Completes

Medtronic said Friday that its $225M acquisition of Carlsbad-based Ablation Frontiers has completed. Medtronic said that it would acquire Ablation Frontiers in January, for $225M plus potential additional milestone payments. Ablation Frontiers will become part of Medtronic's Cardiac Rhythm Disease Management business. Ablation Frontiers was backed by Aberdare Ventures, Affinity Ventures, Hexagon Investments, Novartis Bioventures, Pequot Ventures, Trellis Health Ventures, Venture Lending & Leasing III, Versant Ventures, and WS Investment Company.